{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:15:43Z","timestamp":1783520143454,"version":"3.55.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12324-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:17:57Z","timestamp":1783516677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic potential of natural products in polycystic ovary syndrome"],"prefix":"10.1007","volume":"53","author":[{"given":"Chunmei","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8163-7529","authenticated-orcid":false,"given":"Jianrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"12324_CR1","doi-asserted-by":"publisher","unstructured":"Dokras A (2025) Pcos in 2025 - insights and innovations [J]. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.09.025","DOI":"10.1016\/j.fertnstert.2025.09.025"},{"key":"12324_CR2","doi-asserted-by":"publisher","unstructured":"Chang KJ, Chen JH, Chen KH (2024) The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: A molecular and cellular review of the literature [J]. Int J Mol Sci 25(16). https:\/\/doi.org\/10.3390\/ijms25169037","DOI":"10.3390\/ijms25169037"},{"issue":"1","key":"12324_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","volume":"18","author":"P Su","year":"2025","unstructured":"Su P, Chen C, Sun Y (2025) Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation [J]. J Ovarian Res 18(1):34. https:\/\/doi.org\/10.1186\/s13048-025-01621-6","journal-title":"J Ovarian Res"},{"issue":"10","key":"12324_CR4","doi-asserted-by":"publisher","first-page":"e20889","DOI":"10.1016\/j.heliyon.2023.e20889","volume":"9","author":"W Jung","year":"2023","unstructured":"Jung W, Choi H, Kim J, Kim J, Kim W, Nurkolis F, Kim B (2023) Effects of natural products on polycystic ovary syndrome: From traditional medicine to modern drug discovery [J]. Heliyon 9(10):e20889. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20889","journal-title":"Heliyon"},{"issue":"3","key":"12324_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: Advances and opportunities [J]. Nat Rev Drug Discov 20(3):200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"key":"12324_CR6","doi-asserted-by":"publisher","unstructured":"Muthukumaran D, Kumar J, Shanmugam R (2025) Inducing agents and pcos - a comprehensive analysis [J]. J Steroid Biochem Mol Biol 254(106840). https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106840","DOI":"10.1016\/j.jsbmb.2025.106840"},{"issue":"7","key":"12324_CR7","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1210\/clinem\/dgae917","volume":"110","author":"M Amiri","year":"2025","unstructured":"Amiri M, Hatoum S, Buyalos RP, Sheidaei A, Azziz R (2025) The influence of study quality, age, and geographic factors on pcos prevalence-a systematic review and meta-analysis [J]. J Clin Endocrinol Metab 110(7):2082\u20132103. https:\/\/doi.org\/10.1210\/clinem\/dgae917","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"12324_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","volume":"310","author":"N Salari","year":"2024","unstructured":"Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S, Mohammadi M (2024) Global prevalence of polycystic ovary syndrome in women worldwide: A comprehensive systematic review and meta-analysis [J]. Arch Gynecol Obstet 310(3):1303\u20131314. https:\/\/doi.org\/10.1007\/s00404-024-07607-x","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"12324_CR9","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/humrep\/deac091","volume":"37","author":"S Safiri","year":"2022","unstructured":"Safiri S, Noori M, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Sullman MJM, Collins GS, Kolahi A-A, Avery J (2022) Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990\u20132019 [J]. Hum Reprod 37(8):1919\u20131931. https:\/\/doi.org\/10.1093\/humrep\/deac091","journal-title":"Hum Reprod"},{"issue":"7","key":"12324_CR10","doi-asserted-by":"publisher","first-page":"e0306991","DOI":"10.1371\/journal.pone.0306991","volume":"19","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhu Y, Wang J, Hu H, Jin Y, Mao X, Zhang H, Ye Y, Xin X, Li D (2024) Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: A systematic analysis from the global burden of disease study 2019 [J]. PLoS ONE 19(7):e0306991. https:\/\/doi.org\/10.1371\/journal.pone.0306991","journal-title":"PLoS ONE"},{"issue":"4","key":"12324_CR11","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/ejendo\/lvae125","volume":"191","author":"ACH Neven","year":"2024","unstructured":"Neven ACH, Forslund M, Ranashinha S, Mousa A, Tay CT, Pe\u00f1a A, Oberfield S, Witchel S, Teede H, Boyle JA (2024) Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: A systematic review and meta-analysis [J]. Eur J Endocrinol 191(4):S15\u2013S27. https:\/\/doi.org\/10.1093\/ejendo\/lvae125","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"12324_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s40618-024-02512-1","volume":"48","author":"NG Lafci","year":"2025","unstructured":"Lafci NG, Yilmaz B, Yildiz BO (2025) Pcos - the many faces of a disorder in women and men [J]. J Endocrinol Invest 48(4):785\u2013798. https:\/\/doi.org\/10.1007\/s40618-024-02512-1","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"12324_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1210\/endrev\/bnae002","volume":"45","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang G, Chen J, Wang C, Dong X, Chang HM, Yuan S, Zhao Y, Mu L (2024) Genetic and epigenetic landscape for drug development in polycystic ovary syndrome [J]. Endocr Rev 45(4):437\u2013459. https:\/\/doi.org\/10.1210\/endrev\/bnae002","journal-title":"Endocr Rev"},{"issue":"9","key":"12324_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","volume":"17","author":"E Stener-Victorin","year":"2021","unstructured":"Stener-Victorin E, Deng Q (2021) Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment [J]. Nat Rev Endocrinol 17(9):521\u2013533. https:\/\/doi.org\/10.1038\/s41574-021-00517-x","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"12324_CR15","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/humrep\/dex308","volume":"32","author":"F Tosi","year":"2017","unstructured":"Tosi F, Bonora E, Moghetti P (2017) Insulin resistance in a large cohort of women with polycystic ovary syndrome: A comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes [J]. Hum Reprod 32(12):2515\u20132521. https:\/\/doi.org\/10.1093\/humrep\/dex308","journal-title":"Hum Reprod"},{"key":"12324_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S (2018) Polycystic ovary syndrome (pcos), an inflammatory, systemic, lifestyle endocrinopathy [J]. J Steroid Biochem Mol Biol 182:27\u201336. https:\/\/doi.org\/10.1016\/j.jsbmb.2018.04.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"12324_CR17","doi-asserted-by":"publisher","unstructured":"Bila J, Dotlic J, Andjic M, Ivanovic K, Micic J, Tulic L, Pupovac M, Stojnic J, Vukovic I, Ivanovic S (2025) Obesity as a part of polycysric ovary syndrome (pcos)-a review of pathophysiology and comprehensive therapeutic strategies [J]. J Clin Med 14(16). https:\/\/doi.org\/10.3390\/jcm14165642","DOI":"10.3390\/jcm14165642"},{"issue":"1","key":"12324_CR18","doi-asserted-by":"publisher","first-page":"2357737","DOI":"10.1080\/07853890.2024.2357737","volume":"56","author":"NA Sta\u0144czak","year":"2024","unstructured":"Sta\u0144czak NA, Grywalska E, Dudzi\u0144ska E (2024) The latest reports and treatment methods on polycystic ovary syndrome [J]. Ann Med 56(1):2357737. https:\/\/doi.org\/10.1080\/07853890.2024.2357737","journal-title":"Ann Med"},{"issue":"4","key":"12324_CR19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/jcmm.16205","volume":"25","author":"W Ye","year":"2021","unstructured":"Ye W, Xie T, Song Y, Zhou L (2021) The role of androgen and its related signals in pcos [J]. J Cell Mol Med 25(4):1825\u20131837. https:\/\/doi.org\/10.1111\/jcmm.16205","journal-title":"J Cell Mol Med"},{"issue":"4","key":"12324_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1210\/endrev\/bnae007","volume":"45","author":"RL Rosenfield","year":"2024","unstructured":"Rosenfield RL (2024) The search for the causes of common hyperandrogenism, 1965 to circa 2015 [J]. Endocr Rev 45(4):553\u2013592. https:\/\/doi.org\/10.1210\/endrev\/bnae007","journal-title":"Endocr Rev"},{"key":"12324_CR21","doi-asserted-by":"publisher","unstructured":"Xu Y, Qiao J (2022) Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (pcos): A review of literature [J]. J Healthc Eng 2022(9240569). https:\/\/doi.org\/10.1155\/2022\/9240569","DOI":"10.1155\/2022\/9240569"},{"issue":"6","key":"12324_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications [J]. Endocr Rev 33(6):981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"key":"12324_CR23","doi-asserted-by":"publisher","unstructured":"Cussen L, Mcdonnell T, Miller C, Mcilroy M, O\u2019reilly MW (2025) Polycystic ovary syndrome: Origins and implications: Polycystic ovary syndrome: The impact of androgen excess on metabolic health [J]. Reproduction 170(2). https:\/\/doi.org\/10.1530\/rep-25-0102","DOI":"10.1530\/rep-25-0102"},{"issue":"4","key":"12324_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO (2025) Polycystic ovary syndrome as a metabolic disease [J]. Nat Rev Endocrinol 21(4):230\u2013244. https:\/\/doi.org\/10.1038\/s41574-024-01057-w","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"12324_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13668-023-00479-8","volume":"12","author":"M Di Lorenzo","year":"2023","unstructured":"Di Lorenzo M, Cacciapuoti N, Lonardo MS, Nasti G, Gautiero C, Belfiore A, Guida B, Chiurazzi M (2023) Pathophysiology and nutritional approaches in polycystic ovary syndrome (pcos): A comprehensive review [J]. Curr Nutr Rep 12(3):527\u2013544. https:\/\/doi.org\/10.1007\/s13668-023-00479-8","journal-title":"Curr Nutr Rep"},{"issue":"5","key":"12324_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA (2016) The pathogenesis of polycystic ovary syndrome (pcos): The hypothesis of pcos as functional ovarian hyperandrogenism revisited [J]. Endocr Rev 37(5):467\u2013520 1210\/er.2015-1104%J Endocrine Reviews","journal-title":"Endocr Rev"},{"key":"12324_CR27","doi-asserted-by":"crossref","unstructured":"Ruddenklau A, Campbell RE (2019) Neuroendocrine impairments of polycystic ovary syndrome [J]. Endocrinology, 160(10): 2230\u20132242. DOI: 10.1210\/en.2019-00428%J Endocrinology","DOI":"10.1210\/en.2019-00428"},{"key":"12324_CR28","doi-asserted-by":"publisher","unstructured":"Deng H, Chen Y, Xing J, Zhang N, Xu L (2024) Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome [J]. Front Immunol 15(1470283). https:\/\/doi.org\/10.3389\/fimmu.2024.1470283","DOI":"10.3389\/fimmu.2024.1470283"},{"key":"12324_CR29","doi-asserted-by":"publisher","unstructured":"Liu H, Jin L, Wang X, Shi J, He Y, Sun N, Yang F (2025) Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities [J]. Redox Biol 85(103776). https:\/\/doi.org\/10.1016\/j.redox.2025.103776","DOI":"10.1016\/j.redox.2025.103776"},{"issue":"2","key":"12324_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcp.29912","volume":"236","author":"M Rostamtabar","year":"2021","unstructured":"Rostamtabar M, Esmaeilzadeh S, Tourani M, Rahmani A, Baee M, Shirafkan F, Saleki K, Mirzababayi SS, Ebrahimpour S, Nouri HR (2021) Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome [J]. J Cell Physiol 236(2):824\u2013838. https:\/\/doi.org\/10.1002\/jcp.29912","journal-title":"J Cell Physiol"},{"issue":"3","key":"12324_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ros) and ros-induced ros release [J]. Physiol Rev 94(3):909\u2013950. https:\/\/doi.org\/10.1152\/physrev.00026.2013","journal-title":"Physiol Rev"},{"issue":"1","key":"12324_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12958-024-01337-0","volume":"22","author":"H Yan","year":"2024","unstructured":"Yan H, Wang L, Zhang G, Li N, Zhao Y, Liu J, Jiang M, Du X, Zeng Q, Xiong D, He L, Zhou Z, Luo M, Liu W (2024) Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: From mechanisms to therapeutic strategies [J]. Reprod Biol Endocrinol 22(1):159. https:\/\/doi.org\/10.1186\/s12958-024-01337-0","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"12324_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12958-023-01159-6","volume":"21","author":"AO Awonuga","year":"2023","unstructured":"Awonuga AO, Camp OG, Abu-Soud HM (2023) A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in pcos [J]. Reprod Biol Endocrinol 21(1):111. https:\/\/doi.org\/10.1186\/s12958-023-01159-6","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"12324_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12967-025-06315-7","volume":"23","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar H, Arumugam M (2025) Gut microbiota: A hidden player in polycystic ovary syndrome [J]. J Transl Med 23(1):443. https:\/\/doi.org\/10.1186\/s12967-025-06315-7","journal-title":"J Transl Med"},{"issue":"1","key":"12324_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT (2024) Polycystic ovary syndrome [J]. Nat Rev Dis Primers 10(1):27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"12324_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF (2018) Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment [J]. Nat Rev Endocrinol 14(5):270\u2013284. https:\/\/doi.org\/10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"12324_CR37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","volume":"110","author":"LG Cooney","year":"2018","unstructured":"Cooney LG, Dokras A (2018) Beyond fertility: Polycystic ovary syndrome and long-term health [J]. Fertil Steril 110(5):794\u2013809. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.08.021","journal-title":"Fertil Steril"},{"issue":"1","key":"12324_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"-SPCWG Rotterdam Ea","year":"2004","unstructured":"Rotterdam Ea -SPCWG (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (pcos) [J]. Hum Reprod 19(1):41\u201347. https:\/\/doi.org\/10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"issue":"4","key":"12324_CR39","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1093\/ejendo\/lvaf062","volume":"192","author":"E Vale-Fernandes","year":"2025","unstructured":"Vale-Fernandes E, Pignatelli D, Monteiro MP (2025) Should anti-m\u00fcllerian hormone be a diagnosis criterion for polycystic ovary syndrome? An in-depth review of pros and cons [J]. Eur J Endocrinol 192(4):R29\u2013r43. https:\/\/doi.org\/10.1093\/ejendo\/lvaf062","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"12324_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, L MR, Norman JAB, Mousa RJ, Joham A (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome [J]. Fertil Steril 120(4):767\u2013793. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.07.025","journal-title":"Fertil Steril"},{"key":"12324_CR41","doi-asserted-by":"publisher","unstructured":"Unfer V, Kandaraki E, Pkhaladze L, Roseff S, Vazquez-Levin MH, Lagan\u00e0 AS, Shiao-Yng C, Yap-Garcia MIM, Greene NDE, Soulage CO, Bevilacqua A, Benvenga S, Barbaro D, Pintaudi B, Wdowiak A, Aragona C, Kamenov Z, Appetecchia M, Porcaro G, Hernandez Marin I, Facchinetti F, Chiu T, Pustotina O, Papalou O, Nordio M, Cantelmi T, Cavalli P, Vucenik I, D\u2019anna R, Unfer VR, Dinicola S, Salehpour S, Stringaro A, Montaninno Oliva M, Tugushev M, Prapas N, Bizzarri M, Espinola MSB, Di Lorenzo C, Ozay AC, Nestler J (2024) When one size does not fit all: Reconsidering pcos etiology, diagnosis, clinical subgroups, and subgroup-specific treatments [J]. Endocr Metabolic Sci 14(100159). https:\/\/doi.org\/10.1016\/j.endmts.2024.100159","DOI":"10.1016\/j.endmts.2024.100159"},{"issue":"1","key":"12324_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12958-025-01411-1","volume":"23","author":"R Cannarella","year":"2025","unstructured":"Cannarella R, Rubulotta M, Leonardi A, Crafa A, Calvo A, Barbagallo F, La Vignera S, Calogero AE (2025) Effects of ketogenic diets on polycystic ovary syndrome: A systematic review and meta-analysis [J]. Reprod Biol Endocrinol 23(1):74. https:\/\/doi.org\/10.1186\/s12958-025-01411-1","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"12324_CR43","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/rmb2.12219","volume":"17","author":"A Takasaki","year":"2018","unstructured":"Takasaki A, Tamura I, Okada-Hayashi M, Orita T, Tanabe M, Maruyama S, Shimamura K, Morioka H (2018) Usefulness of intermittent clomiphene citrate treatment for women with polycystic ovarian syndrome that is resistant to standard clomiphene citrate treatment [J]. Reprod Med Biol 17(4):454\u2013458. https:\/\/doi.org\/10.1002\/rmb2.12219","journal-title":"Reprod Med Biol"},{"issue":"8","key":"12324_CR44","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS (2019) Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls [J]. J Endocr Soc 3(8):1545\u20131573. https:\/\/doi.org\/10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"issue":"1","key":"12324_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/uog.18933","volume":"51","author":"MA Gadalla","year":"2018","unstructured":"Gadalla MA, Huang S, Wang R, Norman RJ, Abdullah SA, El Saman AM, Ismail AM, Van Wely M, Mol BWJ (2018) Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: Systematic review and meta-analysis [J]. Ultrasound Obstet Gynecol 51(1):64\u201376. https:\/\/doi.org\/10.1002\/uog.18933","journal-title":"Ultrasound Obstet Gynecol"},{"key":"12324_CR46","doi-asserted-by":"publisher","unstructured":"Leathersich S, Roche C, Hart R (2025) Minimising ohss in women with pcos [J]. Front Endocrinol (Lausanne) 16(1507857). https:\/\/doi.org\/10.3389\/fendo.2025.1507857","DOI":"10.3389\/fendo.2025.1507857"},{"issue":"1","key":"12324_CR47","doi-asserted-by":"publisher","first-page":"10182","DOI":"10.1038\/s41598-019-46644-4","volume":"9","author":"S Manzoor","year":"2019","unstructured":"Manzoor S, Ganie MA, Amin S, Shah ZA, Bhat IA, Yousuf SD, Jeelani H, Kawa IA, Fatima Q, Rashid F (2019) Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with polycystic ovarian syndrome: An observational study [J]. Sci Rep 9(1):10182. https:\/\/doi.org\/10.1038\/s41598-019-46644-4","journal-title":"Sci Rep"},{"issue":"1","key":"12324_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","volume":"21","author":"D Greff","year":"2023","unstructured":"Greff D, Juh\u00e1sz AE, V\u00e1ncsa S, V\u00e1radi A, Sipos Z, Szinte J, Park S, Hegyi P, Nyir\u00e1dy P, \u00c1cs N, V\u00e1rb\u00edr\u00f3 S, Horv\u00e1th EM (2023) Inositol is an effective and safe treatment in polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials [J]. Reprod Biol Endocrinol 21(1):10. https:\/\/doi.org\/10.1186\/s12958-023-01055-z","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"12324_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13048-025-01734-y","volume":"18","author":"KA Padder","year":"2025","unstructured":"Padder KA, Jahan N, Yousuf MA, Shah IA, Bhat GA, Khurshid R, Zargar MH, Ganie MA (2025) Deciphering the interplay between oxidative stress and inflammation in polycystic ovary syndrome: Outcome of a case-control study [J]. J Ovarian Res 18(1):196. https:\/\/doi.org\/10.1186\/s13048-025-01734-y","journal-title":"J Ovarian Res"},{"key":"12324_CR50","doi-asserted-by":"publisher","unstructured":"Wang J, Yin T, Liu S (2023) Dysregulation of immune response in pcos organ system [J]. Front Immunol 14(1169232). https:\/\/doi.org\/10.3389\/fimmu.2023.1169232","DOI":"10.3389\/fimmu.2023.1169232"},{"issue":"Pt 1","key":"12324_CR51","doi-asserted-by":"publisher","first-page":"117281","DOI":"10.1016\/j.bcp.2025.117281","volume":"242","author":"R Hu","year":"2025","unstructured":"Hu R, Huang B, Zhao X, Cui X, Luo P, Mao X, Long C, He Y, Shen Z, Chen J, Peng H, Dong W, Lei X, Zhang S, Zhang J (2025) Low-intensity pulsed ultrasound inhibits the ros\/nf-\u03bab signaling pathway and improves inflammation in ovarian granulosa cells of pcos rats [J]. Biochem Pharmacol 242(Pt 1):117281. https:\/\/doi.org\/10.1016\/j.bcp.2025.117281","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"12324_CR52","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1007\/s10787-025-01809-8","volume":"33","author":"A Siddiqua","year":"2025","unstructured":"Siddiqua A, Malik A, Iqbal U, Sial NT, Mehmood MH, Rehman MFU (2025) Antioxidative and anti-inflammatory effects of carvacrol against polycystic ovary syndrome associated complications using high fat diet and letrozole challenged rat model: A multidisciplinary study cascading in vivo, in vitro, in silico and network pharmacology approaches [J]. Inflammopharmacology 33(8):4703\u20134724. https:\/\/doi.org\/10.1007\/s10787-025-01809-8","journal-title":"Inflammopharmacology"},{"issue":"5","key":"12324_CR53","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/1933719116667218","volume":"24","author":"Z Wang","year":"2017","unstructured":"Wang Z, Zhai D, Zhang D, Bai L, Yao R, Yu J, Cheng W, Yu C (2017) Quercetin decreases insulin resistance in a polycystic ovary syndrome rat model by improving inflammatory microenvironment [J]. Reprod Sci 24(5):682\u2013690. https:\/\/doi.org\/10.1177\/1933719116667218","journal-title":"Reprod Sci"},{"key":"12324_CR54","doi-asserted-by":"publisher","unstructured":"Xia Q, Wang W, Liu Z, Xiao J, Qiao C, Zhao Y, Li B, Liu Y, Peng Y, Yang X, Shi J, Gao X, Wang D (2023) New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties [J]. Eur J Pharmacol 939(175433). https:\/\/doi.org\/10.1016\/j.ejphar.2022.175433","DOI":"10.1016\/j.ejphar.2022.175433"},{"key":"12324_CR55","doi-asserted-by":"publisher","unstructured":"He S, Li H, Zhang Q, Zhao W, Li W, Dai C, Li B, Cheng J, Wu S, Zhou Z, Yang J, Li S (2024) Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression [J]. Phytomedicine 128(155456). https:\/\/doi.org\/10.1016\/j.phymed.2024.155456","DOI":"10.1016\/j.phymed.2024.155456"},{"issue":"1","key":"12324_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12958-020-00684-y","volume":"19","author":"HR Shen","year":"2021","unstructured":"Shen HR, Xu X, Li XL (2021) Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis [J]. Reprod Biol Endocrinol 19(1):3. https:\/\/doi.org\/10.1186\/s12958-020-00684-y","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"12324_CR57","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/biolre\/ioac002","volume":"106","author":"X Miao","year":"2022","unstructured":"Miao X, Cui W (2022) Berberine alleviates lps-induced apoptosis, oxidation, and skewed lineages during mouse preimplantation development\u2020 [J]. Biol Reprod 106(4):699\u2013709. https:\/\/doi.org\/10.1093\/biolre\/ioac002","journal-title":"Biol Reprod"},{"issue":"1","key":"12324_CR58","doi-asserted-by":"publisher","first-page":"29848","DOI":"10.1038\/s41598-024-81034-5","volume":"14","author":"Q Yang","year":"2024","unstructured":"Yang Q, Wan Q, Wang Z (2024) Curcumin mitigates polycystic ovary syndrome in mice by suppressing tlr4\/myd88\/nf-\u03bab signaling pathway activation and reducing intestinal mucosal permeability [J]. Sci Rep 14(1):29848. https:\/\/doi.org\/10.1038\/s41598-024-81034-5","journal-title":"Sci Rep"},{"issue":"3","key":"12324_CR59","doi-asserted-by":"publisher","first-page":"425","DOI":"10.22074\/cellj.2017.4415","volume":"19","author":"S Mohammadi","year":"2017","unstructured":"Mohammadi S, Karimzadeh Bardei L, Hojati V, Ghorbani AG, Nabiuni M (2017) Anti-inflammatory effects of curcumin on insulin resistance index, levels of interleukin-6, c-reactive protein, and liver histology in polycystic ovary syndrome-induced rats [J]. Cell J 19(3):425\u2013433. https:\/\/doi.org\/10.22074\/cellj.2017.4415","journal-title":"Cell J"},{"key":"12324_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioae160","author":"H Wei","year":"2024","unstructured":"Wei H, Zhang Z, Zhang S, Wang J, Cui X, Zhang Z, Yu J, Lei X, Xiuhong Z, Huo P (2024) Resveratrol improves follicular development in pcos rats by inhibiting the inflammatory response and pyroptosis of granulosa cells [J]. Biol Reprod. https:\/\/doi.org\/10.1093\/biolre\/ioae160","journal-title":"Biol Reprod"},{"issue":"3","key":"12324_CR61","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H (2018) The keap1-nrf2 system: A thiol-based sensor-effector apparatus for maintaining redox homeostasis [J]. Physiol Rev 98(3):1169\u20131203. https:\/\/doi.org\/10.1152\/physrev.00023.2017","journal-title":"Physiol Rev"},{"issue":"4","key":"12324_CR62","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/ptr.7749","volume":"37","author":"R Ji","year":"2023","unstructured":"Ji R, Jia F, Chen X, Gao Y, Yang J (2023) Carnosol inhibits kgn cells oxidative stress and apoptosis and attenuates polycystic ovary syndrome phenotypes in mice through keap1-mediated nrf2\/ho-1 activation [J]. Phytother Res 37(4):1405\u20131421. https:\/\/doi.org\/10.1002\/ptr.7749","journal-title":"Phytother Res"},{"issue":"4","key":"12324_CR63","doi-asserted-by":"publisher","first-page":"100563","DOI":"10.1016\/j.repbio.2021.100563","volume":"21","author":"M Taheri","year":"2021","unstructured":"Taheri M, Hayati Roudbari N, Amidi F, Parivar K (2021) The protective effect of sulforaphane against oxidative stress in granulosa cells of patients with polycystic ovary syndrome (pcos) through activation of ampk\/akt\/nrf2 signaling pathway [J]. Reprod Biol 21(4):100563. https:\/\/doi.org\/10.1016\/j.repbio.2021.100563","journal-title":"Reprod Biol"},{"key":"12324_CR64","doi-asserted-by":"publisher","unstructured":"Zhou Q, Ouyang X, Tang H, Wang Y, Hua Y, Li L (2025) Atractylodin alleviates polycystic ovary syndrome by inhibiting granule cells ferroptosis through pyruvate dehydrogenase kinase 4-mediated jak-stat3 pathway [J]. Int Immunopharmacol 146(113817). https:\/\/doi.org\/10.1016\/j.intimp.2024.113817","DOI":"10.1016\/j.intimp.2024.113817"},{"key":"12324_CR65","doi-asserted-by":"publisher","unstructured":"Zhang W, Peng C, Xu L, Zhao Y, Huang C, Lu L (2024) The therapeutic effects of curcumin on polycystic ovary syndrome by upregulating ppar-\u03b3 expression and reducing oxidative stress in a rat model [J]. Front Endocrinol (Lausanne) 15(1494852). https:\/\/doi.org\/10.3389\/fendo.2024.1494852","DOI":"10.3389\/fendo.2024.1494852"},{"issue":"8","key":"12324_CR66","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/cbin.12170","volume":"48","author":"S Jin","year":"2024","unstructured":"Jin S, Wang YS, Huang JC, Wang TT, Li BY, Guo B, Yue ZP (2024) Osthole exhibits the remedial potential for polycystic ovary syndrome mice through nrf2-foxo1-gsh-nf-\u03bab pathway [J]. Cell Biol Int 48(8):1111\u20131123. https:\/\/doi.org\/10.1002\/cbin.12170","journal-title":"Cell Biol Int"},{"issue":"18","key":"12324_CR67","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.1039\/d1fo00684c","volume":"12","author":"M Luo","year":"2021","unstructured":"Luo M, Zheng LW, Wang YS, Huang JC, Yang ZQ, Yue ZP, Guo B (2021) Genistein exhibits therapeutic potential for pcos mice via the er-nrf2-foxo1-ros pathway [J]. Food Funct 12(18):8800\u20138811. https:\/\/doi.org\/10.1039\/d1fo00684c","journal-title":"Food Funct"},{"key":"12324_CR68","doi-asserted-by":"publisher","unstructured":"Zhang G, He M, Wang Z, Zheng J, Zhao D, Nie L, Yuan D, Zhao Z, Wang W, Yue L (2024) Synergistic effect and mechanism of combined astaxanthin and curcumin administration on ovarian function in pcos mice [J]. 12(12):10618\u201310627. https:\/\/doi.org\/10.1002\/fsn3.4597","DOI":"10.1002\/fsn3.4597"},{"key":"12324_CR69","doi-asserted-by":"publisher","unstructured":"Wickenheisser JK, Biegler JM, Nelson-Degrave VL, Legro RS, Strauss JF 3rd, Mcallister JM (2012) Cholesterol side-chain cleavage gene expression in theca cells: Augmented transcriptional regulation and mrna stability in polycystic ovary syndrome [J]. PLoS ONE 7(11):e48963. https:\/\/doi.org\/10.1371\/journal.pone.0048963","DOI":"10.1371\/journal.pone.0048963"},{"key":"12324_CR70","doi-asserted-by":"publisher","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Binti Osman M, Sakinah M, Nordin N, Abdul Hamid H (2022) A review on cyp11a1, cyp17a1, and cyp19a1 polymorphism studies: Candidate susceptibility genes for polycystic ovary syndrome (pcos) and infertility [J]. Genes (Basel) 13(2). https:\/\/doi.org\/10.3390\/genes13020302","DOI":"10.3390\/genes13020302"},{"key":"12324_CR71","doi-asserted-by":"publisher","unstructured":"Wawrzkiewicz-Ja\u0142owiecka A, Kowalczyk K, Trybek P, Jarosz T, Radosz P, Setlak M, Madej P (2020) In search of new therapeutics-molecular aspects of the pcos pathophysiology: Genetics, hormones, metabolism and beyond [J]. Int J Mol Sci 21(19). https:\/\/doi.org\/10.3390\/ijms21197054","DOI":"10.3390\/ijms21197054"},{"issue":"6701","key":"12324_CR72","doi-asserted-by":"publisher","first-page":"eadk5382","DOI":"10.1126\/science.adk5382","volume":"384","author":"Y Liu","year":"2024","unstructured":"Liu Y, Jiang JJ, Du SY, Mu LS, Fan JJ, Hu JC, Ye Y, Ding M, Zhou WY, Yu QH, Xia YF, Xu HY, Shi YJ, Qian SW, Tang Y, Li W, Dang YJ, Dong X, Li XY, Xu CJ, Tang QQ (2024) Artemisinins ameliorate polycystic ovarian syndrome by mediating lonp1-cyp11a1 interaction [J]. Science 384(6701):eadk5382. https:\/\/doi.org\/10.1126\/science.adk5382","journal-title":"Science"},{"issue":"9","key":"12324_CR73","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1002\/ptr.7860","volume":"37","author":"R Rashid","year":"2023","unstructured":"Rashid R, Tripathi R, Singh A, Sarkar S, Kawale A, Bader GN, Gupta S, Gupta RK, Jha RK (2023) Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the sprague dawley rats [J]. Phytother Res 37(9):4018\u20134041. https:\/\/doi.org\/10.1002\/ptr.7860","journal-title":"Phytother Res"},{"key":"12324_CR74","doi-asserted-by":"publisher","unstructured":"Li X, Ye T, Zhu W, Gu J, Zheng Z, Wang C, Zhang X, Geng H, Zhou W, Tan X, Ma Y, Zhang H, Wang X (2025) Isatin ameliorates ovarian inflammation and apoptosis caused by hormonal imbalances in pcos mice [J]. Biochem Pharmacol 239(117083). https:\/\/doi.org\/10.1016\/j.bcp.2025.117083","DOI":"10.1016\/j.bcp.2025.117083"},{"key":"12324_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jnutbio.2017.04.012","volume":"47","author":"T Hu","year":"2017","unstructured":"Hu T, Yuan X, Ye R, Zhou H, Lin J, Zhang C, Zhang H, Wei G, Dong M, Huang Y, Lim W, Liu Q, Lee HJ, Jin W (2017) Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat [J]. J Nutr Biochem 47:21\u201328. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.04.012","journal-title":"J Nutr Biochem"},{"key":"12324_CR76","doi-asserted-by":"publisher","unstructured":"Peng MF, Tian S, Song YG, Li CX, Miao MS, Ren Z, Li M (2021) Effects of total flavonoids from eucommia ulmoides oliv. Leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet [J]. J Ethnopharmacol 273(113947). https:\/\/doi.org\/10.1016\/j.jep.2021.113947","DOI":"10.1016\/j.jep.2021.113947"},{"issue":"3","key":"12324_CR77","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/physrev.00037.2010","volume":"92","author":"L Pinilla","year":"2012","unstructured":"Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M (2012) Kisspeptins and reproduction: Physiological roles and regulatory mechanisms [J]. Physiol Rev 92(3):1235\u20131316. https:\/\/doi.org\/10.1152\/physrev.00037.2010","journal-title":"Physiol Rev"},{"key":"12324_CR78","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.biopha.2018.08.135","volume":"107","author":"Q Hu","year":"2018","unstructured":"Hu Q, Jin J, Zhou H, Yu D, Qian W, Zhong Y, Zhang J, Tang C, Liu P, Zhou Y, Wang X, Sheng L (2018) Crocetin attenuates dht-induced polycystic ovary syndrome in mice via revising kisspeptin neurons [J]. Biomed Pharmacother 107:1363\u20131369. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.135","journal-title":"Biomed Pharmacother"},{"key":"12324_CR79","doi-asserted-by":"publisher","unstructured":"Intharuksa A, Arunotayanun W, Na Takuathung M, Chaichit S, Prasansuklab A, Chaikhong K, Sirichanchuen B, Chupradit S, Koonrungsesomboon N (2025) Daidzein and genistein: Natural phytoestrogens with potential applications in hormone replacement therapy [J]. Int J Mol Sci 26(14). https:\/\/doi.org\/10.3390\/ijms26146973","DOI":"10.3390\/ijms26146973"},{"issue":"4","key":"12324_CR80","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.yfrne.2010.03.003","volume":"31","author":"HB Patisaul","year":"2010","unstructured":"Patisaul HB, Jefferson W (2010) The pros and cons of phytoestrogens [J]. Front Neuroendocrinol 31(4):400\u2013419. https:\/\/doi.org\/10.1016\/j.yfrne.2010.03.003","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"12324_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment [J]. J Ovarian Res 16(1):9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"J Ovarian Res"},{"key":"12324_CR82","doi-asserted-by":"publisher","unstructured":"Heshmati J, Moini A, Sepidarkish M, Morvaridzadeh M, Salehi M, Palmowski A, Mojtahedi MF, Shidfar F (2021) Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial [J]. Phytomedicine 80(153395). https:\/\/doi.org\/10.1016\/j.phymed.2020.153395","DOI":"10.1016\/j.phymed.2020.153395"},{"key":"12324_CR83","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.clnesp.2020.01.005","volume":"36","author":"M Jamilian","year":"2020","unstructured":"Jamilian M, Foroozanfard F, Kavossian E, Aghadavod E, Shafabakhsh R, Hoseini A, Asemi Z (2020) Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial [J]. Clin Nutr ESPEN 36:128\u2013133. https:\/\/doi.org\/10.1016\/j.clnesp.2020.01.005","journal-title":"Clin Nutr ESPEN"},{"issue":"11","key":"12324_CR84","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1210\/jc.2016-1858","volume":"101","author":"B Banaszewska","year":"2016","unstructured":"Banaszewska B, Wroty\u0144ska-Barczy\u0144ska J, Spaczynski RZ, Pawelczyk L, Duleba AJ (2016) Effects of resveratrol on polycystic ovary syndrome: A double-blind, randomized, placebo-controlled trial [J]. J Clin Endocrinol Metab 101(11):4322\u20134328. https:\/\/doi.org\/10.1210\/jc.2016-1858","journal-title":"J Clin Endocrinol Metab"},{"key":"12324_CR85","doi-asserted-by":"publisher","unstructured":"Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, Bernardinelli L, Gasparri C, Peroni G, Perna S (2021) Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: A one-group pretest-post-test explanatory study [J]. Nutrients 13(10). https:\/\/doi.org\/10.3390\/nu13103665","DOI":"10.3390\/nu13103665"},{"issue":"1","key":"12324_CR86","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13048-024-01446-9","volume":"17","author":"H Hooshmandi","year":"2024","unstructured":"Hooshmandi H, Ghadiri-Anari A, Ranjbar AM, Fallahzadeh H, Hosseinzadeh M, Nadjarzadeh A (2024) Effects of licorice extract in combination with a low-calorie diet on obesity indices, glycemic indices, and lipid profiles in overweight\/obese women with polycystic ovary syndrome (pcos): A randomized, double-blind, placebo-controlled trial [J]. J Ovarian Res 17(1):157. https:\/\/doi.org\/10.1186\/s13048-024-01446-9","journal-title":"J Ovarian Res"},{"issue":"1","key":"12324_CR87","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejogrb.2006.10.013","volume":"131","author":"D Armanini","year":"2007","unstructured":"Armanini D, Castello R, Scaroni C, Bonanni G, Faccini G, Pellati D, Bertoldo A, Fiore C, Moghetti P (2007) Treatment of polycystic ovary syndrome with spironolactone plus licorice [J]. Eur J Obstet Gynecol Reprod Biol 131(1):61\u201367. https:\/\/doi.org\/10.1016\/j.ejogrb.2006.10.013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"12324_CR88","doi-asserted-by":"publisher","first-page":"e75616","DOI":"10.7759\/cureus.75616","volume":"16","author":"A Kriplani","year":"2024","unstructured":"Kriplani A, Tank P, Singh P, Maini N, Kaitala S, Kantha GL, Paul J, Shah S, Bhatara U, Sinha A, Singh T, Srivastava S, Malvi A (2024) A phase iii, double-blind, randomized, multicenter, clinical trial to evaluate the efficacy and safety of a fixed-dose combination of metformin hydrochloride and myo-inositol compared to metformin in patients with polycystic ovary syndrome [J]. Cureus 16(12):e75616. https:\/\/doi.org\/10.7759\/cureus.75616","journal-title":"Cureus"},{"key":"12324_CR89","doi-asserted-by":"publisher","unstructured":"Liang A, Zhang W, Wang Q, Huang L, Zhang J, Ma D, Liu K, Li S, Chen X, Li S, Lei X (2022) Resveratrol regulates insulin resistance to improve the glycolytic pathway by activating sirt2 in pcos granulosa cells [J]. Front Nutr 9(1019562). https:\/\/doi.org\/10.3389\/fnut.2022.1019562","DOI":"10.3389\/fnut.2022.1019562"},{"key":"12324_CR90","doi-asserted-by":"publisher","unstructured":"Zhang N, Liu X, Zhuang L, Liu X, Zhao H, Shan Y, Liu Z, Li F, Wang Y, Fang J (2020) Berberine decreases insulin resistance in a pcos rats by improving glut4: Dual regulation of the pi3k\/akt and mapk pathways [J]. Regul Toxicol Pharmacol 110(104544). https:\/\/doi.org\/10.1016\/j.yrtph.2019.104544","DOI":"10.1016\/j.yrtph.2019.104544"},{"key":"12324_CR91","doi-asserted-by":"publisher","unstructured":"Khaled N, El-Bahy AA, Radwan R, Handoussa H, Abdelmaksoud S (2019) Ocimum kilimandscharicum l. Restores ovarian functions in letrozole - induced polycystic ovary syndrome (pcos) in rats: Comparison with metformin [J]. Life Sci 232(116640). https:\/\/doi.org\/10.1016\/j.lfs.2019.116640","DOI":"10.1016\/j.lfs.2019.116640"},{"key":"12324_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04495-z","author":"M Zahra","year":"2025","unstructured":"Zahra M, Shah M, Ahmad F, Zulfiqar F, Tariq A, Iqbal N (2025) A randomized controlled trial comparing the efficacy of resveratrol combined with metformin versus resveratrol monotherapy in the management of polycystic ovary syndrome [J]. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04495-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"12324_CR93","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.fertnstert.2015.10.021","volume":"104","author":"JM Franasiak","year":"2015","unstructured":"Franasiak JM, Scott RT (2015) Jr. Introduction: Microbiome in human reproduction [J]. Fertil Steril 104(6):1341\u20131343. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.10.021","journal-title":"Fertil Steril"},{"issue":"1","key":"12324_CR94","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","volume":"79","author":"K Tremellen","year":"2012","unstructured":"Tremellen K, Pearce K (2012) Dysbiosis of gut microbiota (dogma)--a novel theory for the development of polycystic ovarian syndrome [J]. Med Hypotheses 79(1):104\u2013112. https:\/\/doi.org\/10.1016\/j.mehy.2012.04.016","journal-title":"Med Hypotheses"},{"issue":"4","key":"12324_CR95","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1210\/jc.2017-02153","volume":"103","author":"PJ Torres","year":"2018","unstructured":"Torres PJ, Siakowska M, Banaszewska B, Pawelczyk L, Duleba AJ, Kelley ST, Thackray VG (2018) Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism [J]. J Clin Endocrinol Metab 103(4):1502\u20131511. https:\/\/doi.org\/10.1210\/jc.2017-02153","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"12324_CR96","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, Wang L, Zhang Y, Liang X, Wang L, Gonzalez FJ, Patterson AD, Liu H, Mu L, Zhou Z, Zhao Y, Li R, Liu P, Zhong C, Pang Y, Jiang C, Qiao J (2019) Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome [J]. Nat Med 25(8):1225\u20131233. https:\/\/doi.org\/10.1038\/s41591-019-0509-0","journal-title":"Nat Med"},{"issue":"6","key":"12324_CR97","doi-asserted-by":"publisher","first-page":"e2134","DOI":"10.1210\/clinem\/dgz263","volume":"105","author":"B Jobira","year":"2020","unstructured":"Jobira B, Frank DN, Pyle L, Silveira LJ, Kelsey MM, Garcia-Reyes Y, Robertson CE, Ir D, Nadeau KJ, Cree-Green M (2020) Obese adolescents with pcos have altered biodiversity and relative abundance in gastrointestinal microbiota [J]. J Clin Endocrinol Metab 105(6):e2134\u20132144. https:\/\/doi.org\/10.1210\/clinem\/dgz263","journal-title":"J Clin Endocrinol Metab"},{"key":"12324_CR98","doi-asserted-by":"publisher","unstructured":"Shoaei T, Heidari-Beni M, Tehrani HG, Feizi A, Esmaillzadeh A, Askari G (2015) Effects of probiotic supplementation on pancreatic \u03b2-cell function and c-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial [J]. Int J Prev Med 6(27). https:\/\/doi.org\/10.4103\/2008-7802.153866","DOI":"10.4103\/2008-7802.153866"},{"issue":"4","key":"12324_CR99","doi-asserted-by":"publisher","first-page":"e0153196","DOI":"10.1371\/journal.pone.0153196","volume":"11","author":"Y Guo","year":"2016","unstructured":"Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y, Tang L (2016) Association between polycystic ovary syndrome and gut microbiota [J]. PLoS ONE 11(4):e0153196. https:\/\/doi.org\/10.1371\/journal.pone.0153196","journal-title":"PLoS ONE"},{"key":"12324_CR100","doi-asserted-by":"publisher","unstructured":"Li S, Lu R, Zhou B, Wan R, Yan Y, He J, Wu J, Feng X, Yang X, Liang X (2025) Mogroside-rich extract alleviates the inflammation state in polycystic ovary syndrome rats through modulating intestinal microbiota-metabolic axis and suppressing the nf-\u03bab\/nlrp3 pathway [J]. J Steroid Biochem Mol Biol 253(106821). https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106821","DOI":"10.1016\/j.jsbmb.2025.106821"},{"issue":"9","key":"12324_CR101","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1002\/ptr.70043","volume":"39","author":"G Dai","year":"2025","unstructured":"Dai G, Zhang Y, Shen C, Jiao Y, Shen W, Yu F, Liu R, Wang D, Yuan G, Jia J (2025) Luteolin treats obese rats with polycystic ovary syndrome by improving liver lipid metabolism and regulating the gut microbiota [J]. Phytother Res 39(9):4171\u20134180. https:\/\/doi.org\/10.1002\/ptr.70043","journal-title":"Phytother Res"},{"issue":"20","key":"12324_CR102","doi-asserted-by":"publisher","first-page":"e2412558","DOI":"10.1002\/advs.202412558","volume":"12","author":"L Geng","year":"2025","unstructured":"Geng L, Yang X, Sun J, Ran X, Zhou D, Ye M, Wen L, Wang R, Chen M (2025) Gut microbiota modulation by inulin improves metabolism and ovarian function in polycystic ovary syndrome [J]. Adv Sci (Weinh) 12(20):e2412558. https:\/\/doi.org\/10.1002\/advs.202412558","journal-title":"Adv Sci (Weinh)"},{"key":"12324_CR103","doi-asserted-by":"publisher","unstructured":"Kukaev E, Kirillova E, Tokareva A, Rimskaya E, Starodubtseva N, Chernukha G, Priputnevich T, Frankevich V, Sukhikh G (2024) Impact of gut microbiota and scfas in the pathogenesis of pcos and the effect of metformin therapy [J]. Int J Mol Sci 25(19). https:\/\/doi.org\/10.3390\/ijms251910636","DOI":"10.3390\/ijms251910636"},{"issue":"17","key":"12324_CR104","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.1039\/d4fo01059k","volume":"15","author":"S Tian","year":"2024","unstructured":"Tian S, Lei Y, Zhao F, Che J, Wu Y, Lei P, Kang YE, Shan Y (2024) Improving insulin resistance by sulforaphane via activating the bacteroides and lactobacillus scfas-gpr-glp1 signal axis [J]. Food Funct 15(17):8644\u20138660. https:\/\/doi.org\/10.1039\/d4fo01059k","journal-title":"Food Funct"},{"issue":"1","key":"12324_CR105","doi-asserted-by":"publisher","first-page":"2236749","DOI":"10.1080\/19490976.2023.2236749","volume":"15","author":"S Hu","year":"2023","unstructured":"Hu S, Ding Q, Zhang W, Kang M, Ma J, Zhao L (2023) Gut microbial beta-glucuronidase: A vital regulator in female estrogen metabolism [J]. Gut Microbes 15(1):2236749. https:\/\/doi.org\/10.1080\/19490976.2023.2236749","journal-title":"Gut Microbes"},{"issue":"1","key":"12324_CR106","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13048-024-01354-y","volume":"17","author":"P Zhou","year":"2024","unstructured":"Zhou P, Feng P, Liao B, Fu L, Shan H, Cao C, Luo R, Peng T, Liu F, Li R (2024) Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome [J]. J Ovarian Res 17(1):69. https:\/\/doi.org\/10.1186\/s13048-024-01354-y","journal-title":"J Ovarian Res"},{"issue":"3","key":"12324_CR107","doi-asserted-by":"publisher","first-page":"149","DOI":"10.29252\/ijrm.16.3.149","volume":"16","author":"M Ghowsi","year":"2018","unstructured":"Ghowsi M, Khazali H, Sisakhtnezhad S (2018) The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: An experimental study [J]. Int J Reprod Biomed 16(3):149\u2013158","journal-title":"Int J Reprod Biomed"},{"key":"12324_CR108","doi-asserted-by":"publisher","unstructured":"Ortega I, Villanueva JA, Wong DH, Cress AB, Sokalska A, Stanley SD, Duleba AJ (2014) Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis [J]. J Ovarian Res 7(21). https:\/\/doi.org\/10.1186\/1757-2215-7-21","DOI":"10.1186\/1757-2215-7-21"},{"issue":"2","key":"12324_CR109","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7150\/thno.67167","volume":"12","author":"M Chen","year":"2022","unstructured":"Chen M, He C, Zhu K, Chen Z, Meng Z, Jiang X, Cai J, Yang C, Zuo Z (2022) Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication [J]. Theranostics 12(2):782\u2013795. https:\/\/doi.org\/10.7150\/thno.67167","journal-title":"Theranostics"},{"issue":"6","key":"12324_CR110","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jfma.2021.08.015","volume":"121","author":"S Zheng","year":"2022","unstructured":"Zheng S, Chen Y, Ma M, Li M (2022) Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian cnp\/npr2 in pcos model rats [J]. J Formos Med Assoc 121(6):1081\u20131092. https:\/\/doi.org\/10.1016\/j.jfma.2021.08.015","journal-title":"J Formos Med Assoc"},{"key":"12324_CR111","doi-asserted-by":"publisher","unstructured":"Olaniyan OT, Bamidele O, Adetunji CO, Priscilla B, Femi A, Ayobami D, Okotie G, Oluwaseun I, Olugbenga E, Mali PC (2020) Quercetin modulates granulosa cell mrna androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in wistar rats via metabolic and hormonal pathways [J]. J Basic Clin Physiol Pharmacol 31(4). https:\/\/doi.org\/10.1515\/jbcpp-2019-0076","DOI":"10.1515\/jbcpp-2019-0076"},{"key":"12324_CR112","doi-asserted-by":"publisher","unstructured":"Scannell N, Mantzioris E, Rao V, Pandey C, Ee C, Mousa A, Moran L, Villani A (2023) Type and frequency in use of nutraceutical and micronutrient supplementation for the management of polycystic ovary syndrome: A systematic scoping review [J]. Biomedicines 11(12). https:\/\/doi.org\/10.3390\/biomedicines11123349","DOI":"10.3390\/biomedicines11123349"},{"issue":"4","key":"12324_CR113","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/advances\/nmab141","volume":"13","author":"S Alesi","year":"2022","unstructured":"Alesi S, Ee C, Moran LJ, Rao V, Mousa A (2022) Nutritional supplements and complementary therapies in polycystic ovary syndrome [J]. Adv Nutr 13(4):1243\u20131266. https:\/\/doi.org\/10.1093\/advances\/nmab141","journal-title":"Adv Nutr"},{"issue":"1","key":"12324_CR114","doi-asserted-by":"publisher","first-page":"15910","DOI":"10.1038\/s41598-020-72694-0","volume":"10","author":"TY Huang","year":"2020","unstructured":"Huang TY, Yu CP, Hsieh YW, Lin SP, Hou YC (2020) Resveratrol stereoselectively affected (\u00b1)warfarin pharmacokinetics and enhanced the anticoagulation effect [J]. Sci Rep 10(1):15910. https:\/\/doi.org\/10.1038\/s41598-020-72694-0","journal-title":"Sci Rep"},{"issue":"14","key":"12324_CR115","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1021\/jf040059f","volume":"52","author":"JR Sheu","year":"2004","unstructured":"Sheu JR, Hsiao G, Chou PH, Shen MY, Chou DS (2004) Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets [J]. J Agric Food Chem 52(14):4414\u20134418. https:\/\/doi.org\/10.1021\/jf040059f","journal-title":"J Agric Food Chem"},{"key":"12324_CR116","doi-asserted-by":"publisher","unstructured":"Huang M, Deng M, Nie W, Zou D, Wu H, Xu D (2021) Naringenin inhibits platelet activation and arterial thrombosis through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling [J]. Front Pharmacol 12(722257). https:\/\/doi.org\/10.3389\/fphar.2021.722257","DOI":"10.3389\/fphar.2021.722257"},{"issue":"5","key":"12324_CR117","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1007\/s00044-013-0829-4","volume":"23","author":"M Bijak","year":"2014","unstructured":"Bijak M, Ziewiecki R, Saluk J, Ponczek M, Pawlaczyk I, Krotkiewski H, Wachowicz B, Nowak P (2014) Thrombin inhibitory activity of some polyphenolic compounds [J]. Med Chem Res 23(5):2324\u20132337. https:\/\/doi.org\/10.1007\/s00044-013-0829-4","journal-title":"Med Chem Res"},{"key":"12324_CR118","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijbiomac.2014.01.023","volume":"65","author":"M Bijak","year":"2014","unstructured":"Bijak M, Ponczek MB, Nowak P (2014) Polyphenol compounds belonging to flavonoids inhibit activity of coagulation factor x [J]. Int J Biol Macromol 65:129\u2013135. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.01.023","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"12324_CR119","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ptr.5970","volume":"32","author":"M Hajimonfarednejad","year":"2018","unstructured":"Hajimonfarednejad M, Nimrouzi M, Heydari M, Zarshenas MM, Raee MJ, Jahromi BN (2018) Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial [J]. Phytother Res 32(2):276\u2013283. https:\/\/doi.org\/10.1002\/ptr.5970","journal-title":"Phytother Res"},{"issue":"6","key":"12324_CR120","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","volume":"109","author":"V Fitz","year":"2024","unstructured":"Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A, Armour M, Rao V, Naidoo D, Maunder A, Yang G, Vaddiparthi V, Witchel SF, Pena A, Spritzer PM, Li R, Tay C, Mousa A, Teede H, Ee C (2024) Inositol for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 update of the international evidence-based pcos guidelines [J]. J Clin Endocrinol Metab 109(6):1630\u20131655. https:\/\/doi.org\/10.1210\/clinem\/dgad762","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"12324_CR121","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ijms11041321","volume":"11","author":"M D\u2019archivio","year":"2010","unstructured":"D\u2019archivio M, Filesi C, Var\u00ec R, Scazzocchio B, Masella R (2010) Bioavailability of the polyphenols: Status and controversies [J]. Int J Mol Sci 11(4):1321\u20131342. https:\/\/doi.org\/10.3390\/ijms11041321","journal-title":"Int J Mol Sci"},{"key":"12324_CR122","doi-asserted-by":"publisher","unstructured":"Di Lorenzo C, Colombo F, Biella S, Stockley C, Restani P (2021) Polyphenols and human health: The role of bioavailability [J]. Nutrients 13(1). https:\/\/doi.org\/10.3390\/nu13010273","DOI":"10.3390\/nu13010273"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12324-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:17:59Z","timestamp":1783516679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12324-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12324"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12324-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1118"}}